Triamcinolone Acetonide
NDC Package 74157-901-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Triamcinolone Acetonide is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Marketed by Ina Pharmaceutics, Inc., this product is identified by NDC 74157-901 and is authorized under FDA application ANDA212356.

Identification & Billing

NDC Package Code
74157-901-90
Package Description
430 g in 1 JAR
Product Code
74157-901
11-Digit Billing Format
74157090190
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
430 GM

Clinical Specifications

Proprietary Name
Triamcinolone Acetonide
Dosage Form
-
Usage Information
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist.

Regulatory & Marketing

Labeler Name
Ina Pharmaceutics, Inc.
FDA Application #
ANDA212356
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-01-2020
End Marketing Date
09-01-2023
Listing Expiration
09-01-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 74157-901-90 identifies a specific commercial package of 430 g in 1 jar of Triamcinolone Acetonide, labeled by Ina Pharmaceutics, Inc.. This product is billed per "GM" gram and contains an estimated amount of 430 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ina Pharmaceutics, Inc. on August 01, 2020. The current certification is valid through September 01, 2023.

What are the primary indications for this medication?

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist.

How is this Ina Pharmaceutics, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 74157090190. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 430 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
74157-901-90
11-Digit CMS (5-4-2)
74157-0901-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.